0000313143-15-000077.txt : 20150811
0000313143-15-000077.hdr.sgml : 20150811
20150811182947
ACCESSION NUMBER: 0000313143-15-000077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150721
FILED AS OF DATE: 20150811
DATE AS OF CHANGE: 20150811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0328
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fusco David
CENTRAL INDEX KEY: 0001649182
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 151045154
MAIL ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRIANTREE
STATE: MA
ZIP: 02184
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-07-21
0
0000313143
HAEMONETICS CORP
HAE
0001649182
Fusco David
721 WEST ROXBURY PARKWAY
BOSTON
MA
02132
0
1
0
0
EVP, Global Human Resources
Common Stock
2015-07-21
4
A
0
2679.0
0.0
A
2679
D
Non-Qualified Stock Option (right to buy)
39.1908
2015-07-21
4
A
0
27404.0
0.0
A
2016-07-21
2022-07-21
Common Stock
27404
27404
D
Performance Shares
0.0
2015-07-21
4
A
0
11250.0
0.0
A
2017-09-30
2017-12-31
Common Stock
11250
11250
D
Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Company?s stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d)..
By: Alexander Steffan For: David Fusco
2015-08-11